Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1993725 citationsJournal Article

Authors

The early administration of TI in the combined modality therapy of limited-stage SCLC is superior to late or consolidative TI.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 11, Issue 2, pp. 336-344

Field-Weighted Citation Impact: 10.23